KP Rx

Karst Peak Rx (KP Rx) is a healthcare investor, backed by Karst Peak Capital, specialising in healthcare and health tech investments in Australia and New Zealand (ANZ). We focus on investments in private and early-stage public companies, with an emphasis on biotech, medical devices, diagnostics and healthtech. KP Rx Healthcare Opportunities Fund The KP Rx Healthcare Opportunities Fund is designed to capitalise on the severe lack of capital dedicated to healthcare commercialisation in ANZ, targeting undervalued early-stage opportunities with significant near-term upside potential. By partnering with healthcare companies at Phase 2/3 or early commercialisation stages, KP Rx can leverage its knowledge and expertise through the later stages of development and commercialisation to unlock material value for business owners and shareholders along the way. The Fund is structured as a closed-ended Venture Capital Limited Partner (VCLP) with a 10-year life. The cornerstone investors include Karst Peak Capital, Australian family offices and a group of Australia’s most successful healthcare entrepreneurs.